| P50 | author | Rebekah Feng | Q56955836 |
| P2093 | author name string | Sean P Collins | |
| | Simeng Suy | |
| | Leorey N Saligan | |
| P2860 | cites work | Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family | Q24315643 |
| | Cell atrophy and loss in depression: reversal by antidepressant treatment | Q27013609 |
| | Getting TRAIL back on track for cancer therapy | Q27027460 |
| | Following a TRAIL: update on a ligand and its five receptors | Q28292767 |
| | The blood brain barrier and the role of cytokines in neuropsychiatry | Q30437437 |
| | The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association | Q33846043 |
| | Cancer-Related Fatigue, Version 2.2015. | Q33878583 |
| | Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) | Q34146143 |
| | Effects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes | Q34496935 |
| | Apo2L/TRAIL and its death and decoy receptors | Q34532325 |
| | Cytokine-induced sickness behavior: mechanisms and implications | Q34631070 |
| | Cancer-related follow-up care among Hispanic and non-Hispanic childhood cancer survivors: The Project Forward study | Q35058480 |
| | Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks | Q35681678 |
| | Perceived Fatigue Interference and Depressed Mood: Comparison of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients with Fatigued Breast Cancer Survivors | Q35845681 |
| | Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression | Q35923297 |
| | Biomarkers: symptoms, survivorship, and quality of life | Q35923511 |
| | Regulation in the targeting of TRAIL receptor 1 to cell surface via GODZ for TRAIL sensitivity in tumor cells | Q36028494 |
| | T lymphocytes and normal tissue responses to radiation | Q36244299 |
| | Cancer-related fatigue--mechanisms, risk factors, and treatments | Q36332266 |
| | Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways | Q36456667 |
| | Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience | Q36722591 |
| | Neuronal damage in brain inflammation | Q36734517 |
| | The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors | Q37086114 |
| | Neuroinflammation, neurodegeneration, and depression. | Q37116106 |
| | Cancer fatigue: a review for psychiatrists | Q37146680 |
| | Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications | Q37370372 |
| | The neuroimmune basis of fatigue | Q37470201 |
| | Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications | Q37688991 |
| | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling and cell death in the immature central nervous system after hypoxia-ischemia and inflammation. | Q37691639 |
| | Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury | Q37693239 |
| | Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity | Q37702326 |
| | Histopathologic Effects of Hypofractionated Robotic Radiation Therapy on Malignant and Benign Prostate Tissue | Q37808695 |
| | Neurons as targets for T cells in the nervous system. | Q38088075 |
| | Non-targeted effects induced by ionizing radiation: mechanisms and potential impact on radiation induced health effects | Q38138288 |
| | Clinical Predictors of Fatigue in Men With Non-Metastatic Prostate Cancer Receiving External Beam Radiation Therapy. | Q38638440 |
| | The role of inflammation in depression: from evolutionary imperative to modern treatment target | Q38681725 |
| | Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy. | Q38815010 |
| | The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. | Q39467783 |
| | Increased mitochondrial mass in cells with functionally compromised mitochondria after exposure to both direct gamma radiation and bystander factors | Q40088897 |
| | Accumulation of the common mitochondrial DNA deletion induced by ionizing radiation | Q40530947 |
| | Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity | Q40661645 |
| | Non-targeted effects of radiation exposure: recent advances and implications | Q41035436 |
| | Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus | Q41652637 |
| | Severity classification on the Hamilton Depression Rating Scale | Q43656374 |
| | Pain, depression, and fatigue as a symptom cluster in advanced cancer | Q43820922 |
| | Persistent oxidative stress in chromosomally unstable cells | Q44480725 |
| | A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer | Q45351617 |
| | Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up | Q46158698 |
| | Validity and reliability of the Hamilton depression rating scale (5 items) for manic and mixed bipolar disorders | Q46730628 |
| | The experience of fatigue, other symptoms and global quality of life during radiotherapy for uterine cancer | Q48555049 |
| | Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL. | Q48894792 |
| | Different Phenotyping Approaches Lead to Dissimilar Biologic Profiles in Men With Chronic Fatigue After Radiation Therapy. | Q50308378 |
| | Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q52908090 |
| | The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments. | Q53848264 |
| | Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer | Q62514147 |
| | Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system | Q73206828 |
| | Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales | Q78846097 |
| | Expression of the TRAIL receptors in blood mononuclear cells in leukemia | Q80406336 |
| | Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes | Q81789732 |
| | Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis | Q84461412 |
| | Cancer-Related Fatigue: Definitions and Clinical Subtypes | Q85093460 |
| P304 | page(s) | 130-138 | |
| P577 | publication date | 2017-03-20 | |
| P1433 | published in | Journal of Psychiatric Research | Q6295810 |
| P1476 | title | The role of TRAIL in fatigue induced by repeated stress from radiotherapy | |
| P478 | volume | 91 | |